ZEVIPTO Trademark

Trademark Overview


On Wednesday, November 8, 2023, a trademark application was filed for ZEVIPTO with the United States Patent and Trademark Office. The USPTO has given the ZEVIPTO trademark a serial number of 79386352. The federal status of this trademark filing is REVIVED - AWAITING FURTHER ACTION as of Thursday, August 15, 2024. This trademark is owned by Novartis AG. The ZEVIPTO trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and diso...
zevipto

General Information


Serial Number79386352
Word MarkZEVIPTO
Filing DateWednesday, November 8, 2023
Status616 - REVIVED - AWAITING FURTHER ACTION
Status DateThursday, August 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma; all of the above with the exception of pharmaceuticals for the prevention and treatment of central nervous system diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 17, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCH

Trademark Events


Event DateEvent Description
Thursday, December 28, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, December 29, 2023LIMITATION FROM ORIGINAL APPLICATION ENTERED
Wednesday, January 17, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 18, 2024ASSIGNED TO EXAMINER
Tuesday, January 23, 2024APPLICATION FILING RECEIPT MAILED
Wednesday, January 24, 2024NON-FINAL ACTION WRITTEN
Thursday, January 25, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, February 5, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, February 5, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, February 5, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, February 5, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, February 5, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, February 5, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, February 13, 2024REFUSAL PROCESSED BY MPU
Tuesday, February 13, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, March 5, 2024REFUSAL PROCESSED BY IB
Thursday, August 15, 2024PETITION TO REVIVE-GRANTED
Thursday, August 15, 2024NOTICE OF REVIVAL - E-MAILED
Thursday, August 15, 2024TEAS PETITION TO REVIVE RECEIVED
Thursday, August 15, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 6, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 6, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 6, 2024ASSIGNED TO LIE